Advertisement

Topics

Daiichi's Pexidartinib Likely Needs REMS For Liver Safety Concerns

13:21 EDT 13 May 2019 | SCRIP

REMS with provider and pharmacy certification could help address hepatotoxicity worries for the tenosynovial giant cell tumor treatment, but Daiichi likely...

      

Related Stories

 

Original Article: Daiichi's Pexidartinib Likely Needs REMS For Liver Safety Concerns

NEXT ARTICLE

More From BioPortfolio on "Daiichi's Pexidartinib Likely Needs REMS For Liver Safety Concerns"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...